USA Intravenous Immunoglobulins Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Immunoglobulin therapy is the use of a mixture of antibodies (immunoglobulins) to treat a number of health conditions. These conditions include primary immunodeficiency, idiopathic thrombocytopenic purpura, chronic inflammatory demyelinating polyneuropathy, Kawasaki disease, certain cases of HIV/AIDS and measles, Guillain-Barré syndrome, and in certain other infections when a more specific immunoglobulin is not available. Depending on the formulation it can be given by injection into muscle, a vein, or under the skin.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Intravenous Immunoglobulins market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Intravenous Immunoglobulins market. Detailed analysis of key players, along with key growth strategies adopted by Intravenous Immunoglobulins industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Octapharma

    • Grifols

    • Sanquin

    • Bayer

    • CSL Behring

    • ADMA Biologics

    • Kedrion Biopharma

    • Biotest

    • China Biologic Products

    • Hualan Biological Engineering

    • Shire

    • Bharat Serum and Vaccines

    • LFB Group

    By Type:

    • Neurology Intravenous Immunoglobulins

    • Hematology Intravenous Immunoglobulins

    • Immunology Intravenous Immunoglobulins

    By End-User:

    • Primary Immunodeficiency

    • Idiopathic Thrombocytopenic Purpura

    • Chronic Inflammatory Demyelinating Polyneuropathy

    • Kawasaki Disease

    • Guillain-Barre Syndrome

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Intravenous Immunoglobulins Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Intravenous Immunoglobulins Market Size and Growth Rate of Neurology Intravenous Immunoglobulins from 2016 to 2027

      • 1.3.2 USA Intravenous Immunoglobulins Market Size and Growth Rate of Hematology Intravenous Immunoglobulins from 2016 to 2027

      • 1.3.3 USA Intravenous Immunoglobulins Market Size and Growth Rate of Immunology Intravenous Immunoglobulins from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Intravenous Immunoglobulins Market Size and Growth Rate of Primary Immunodeficiency from 2016 to 2027

      • 1.4.2 USA Intravenous Immunoglobulins Market Size and Growth Rate of Idiopathic Thrombocytopenic Purpura from 2016 to 2027

      • 1.4.3 USA Intravenous Immunoglobulins Market Size and Growth Rate of Chronic Inflammatory Demyelinating Polyneuropathy from 2016 to 2027

      • 1.4.4 USA Intravenous Immunoglobulins Market Size and Growth Rate of Kawasaki Disease from 2016 to 2027

      • 1.4.5 USA Intravenous Immunoglobulins Market Size and Growth Rate of Guillain-Barre Syndrome from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Intravenous Immunoglobulins Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Intravenous Immunoglobulins Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Intravenous Immunoglobulins Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Intravenous Immunoglobulins Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Intravenous Immunoglobulins Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Intravenous Immunoglobulins by Major Types

      • 3.4.1 Market Size and Growth Rate of Neurology Intravenous Immunoglobulins

      • 3.4.2 Market Size and Growth Rate of Hematology Intravenous Immunoglobulins

      • 3.4.3 Market Size and Growth Rate of Immunology Intravenous Immunoglobulins

    4 Segmentation of Intravenous Immunoglobulins Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Intravenous Immunoglobulins by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Intravenous Immunoglobulins in Primary Immunodeficiency

      • 4.4.2 Market Size and Growth Rate of Intravenous Immunoglobulins in Idiopathic Thrombocytopenic Purpura

      • 4.4.3 Market Size and Growth Rate of Intravenous Immunoglobulins in Chronic Inflammatory Demyelinating Polyneuropathy

      • 4.4.4 Market Size and Growth Rate of Intravenous Immunoglobulins in Kawasaki Disease

      • 4.4.5 Market Size and Growth Rate of Intravenous Immunoglobulins in Guillain-Barre Syndrome

    5 Market Analysis by Regions

    • 5.1 USA Intravenous Immunoglobulins Production Analysis by Regions

    • 5.2 USA Intravenous Immunoglobulins Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Intravenous Immunoglobulins Landscape Analysis

    • 6.1 West USA Intravenous Immunoglobulins Landscape Analysis by Major Types

    • 6.2 West USA Intravenous Immunoglobulins Landscape Analysis by Major End-Users

    7 South USA Intravenous Immunoglobulins Landscape Analysis

    • 7.1 South USA Intravenous Immunoglobulins Landscape Analysis by Major Types

    • 7.2 South USA Intravenous Immunoglobulins Landscape Analysis by Major End-Users

    8 Middle West USA Intravenous Immunoglobulins Landscape Analysis

    • 8.1 Middle West USA Intravenous Immunoglobulins Landscape Analysis by Major Types

    • 8.2 Middle West USA Intravenous Immunoglobulins Landscape Analysis by Major End-Users

    9 Northeast USA Intravenous Immunoglobulins Landscape Analysis

    • 9.1 Northeast USA Intravenous Immunoglobulins Landscape Analysis by Major Types

    • 9.2 Northeast USA Intravenous Immunoglobulins Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Octapharma

        • 10.1.1 Octapharma Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Grifols

        • 10.2.1 Grifols Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Sanquin

        • 10.3.1 Sanquin Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Bayer

        • 10.4.1 Bayer Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 CSL Behring

        • 10.5.1 CSL Behring Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 ADMA Biologics

        • 10.6.1 ADMA Biologics Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Kedrion Biopharma

        • 10.7.1 Kedrion Biopharma Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Biotest

        • 10.8.1 Biotest Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 China Biologic Products

        • 10.9.1 China Biologic Products Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Hualan Biological Engineering

        • 10.10.1 Hualan Biological Engineering Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Shire

        • 10.11.1 Shire Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Bharat Serum and Vaccines

        • 10.12.1 Bharat Serum and Vaccines Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 LFB Group

        • 10.13.1 LFB Group Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Intravenous Immunoglobulins Market Size and Growth Rate of Neurology Intravenous Immunoglobulins from 2016 to 2027

    • Figure USA Intravenous Immunoglobulins Market Size and Growth Rate of Hematology Intravenous Immunoglobulins from 2016 to 2027

    • Figure USA Intravenous Immunoglobulins Market Size and Growth Rate of Immunology Intravenous Immunoglobulins from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Intravenous Immunoglobulins Market Size and Growth Rate of Primary Immunodeficiency from 2016 to 2027

    • Figure USA Intravenous Immunoglobulins Market Size and Growth Rate of Idiopathic Thrombocytopenic Purpura from 2016 to 2027

    • Figure USA Intravenous Immunoglobulins Market Size and Growth Rate of Chronic Inflammatory Demyelinating Polyneuropathy from 2016 to 2027

    • Figure USA Intravenous Immunoglobulins Market Size and Growth Rate of Kawasaki Disease from 2016 to 2027

    • Figure USA Intravenous Immunoglobulins Market Size and Growth Rate of Guillain-Barre Syndrome from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Intravenous Immunoglobulins Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Intravenous Immunoglobulins Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Intravenous Immunoglobulins Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Intravenous Immunoglobulins Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Intravenous Immunoglobulins Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Intravenous Immunoglobulins

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Intravenous Immunoglobulins by Different Types from 2016 to 2027

    • Table Consumption Share of Intravenous Immunoglobulins by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Neurology Intravenous Immunoglobulins

    • Figure Market Size and Growth Rate of Hematology Intravenous Immunoglobulins

    • Figure Market Size and Growth Rate of Immunology Intravenous Immunoglobulins

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Intravenous Immunoglobulins by Different End-Users from 2016 to 2027

    • Table Consumption Share of Intravenous Immunoglobulins by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Primary Immunodeficiency

    • Figure Market Size and Growth Rate of Idiopathic Thrombocytopenic Purpura

    • Figure Market Size and Growth Rate of Chronic Inflammatory Demyelinating Polyneuropathy

    • Figure Market Size and Growth Rate of Kawasaki Disease

    • Figure Market Size and Growth Rate of Guillain-Barre Syndrome

    • Table USA Intravenous Immunoglobulins Production by Regions

    • Table USA Intravenous Immunoglobulins Production Share by Regions

    • Figure USA Intravenous Immunoglobulins Production Share by Regions in 2016

    • Figure USA Intravenous Immunoglobulins Production Share by Regions in 2021

    • Figure USA Intravenous Immunoglobulins Production Share by Regions in 2027

    • Table USA Intravenous Immunoglobulins Consumption by Regions

    • Table USA Intravenous Immunoglobulins Consumption Share by Regions

    • Figure USA Intravenous Immunoglobulins Consumption Share by Regions in 2016

    • Figure USA Intravenous Immunoglobulins Consumption Share by Regions in 2021

    • Figure USA Intravenous Immunoglobulins Consumption Share by Regions in 2027

    • Table West USA Intravenous Immunoglobulins Consumption by Types from 2016 to 2027

    • Table West USA Intravenous Immunoglobulins Consumption Share by Types from 2016 to 2027

    • Figure West USA Intravenous Immunoglobulins Consumption Share by Types in 2016

    • Figure West USA Intravenous Immunoglobulins Consumption Share by Types in 2021

    • Figure West USA Intravenous Immunoglobulins Consumption Share by Types in 2027

    • Table West USA Intravenous Immunoglobulins Consumption by End-Users from 2016 to 2027

    • Table West USA Intravenous Immunoglobulins Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Intravenous Immunoglobulins Consumption Share by End-Users in 2016

    • Figure West USA Intravenous Immunoglobulins Consumption Share by End-Users in 2021

    • Figure West USA Intravenous Immunoglobulins Consumption Share by End-Users in 2027

    • Table South USA Intravenous Immunoglobulins Consumption by Types from 2016 to 2027

    • Table South USA Intravenous Immunoglobulins Consumption Share by Types from 2016 to 2027

    • Figure South USA Intravenous Immunoglobulins Consumption Share by Types in 2016

    • Figure South USA Intravenous Immunoglobulins Consumption Share by Types in 2021

    • Figure South USA Intravenous Immunoglobulins Consumption Share by Types in 2027

    • Table South USA Intravenous Immunoglobulins Consumption by End-Users from 2016 to 2027

    • Table South USA Intravenous Immunoglobulins Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Intravenous Immunoglobulins Consumption Share by End-Users in 2016

    • Figure South USA Intravenous Immunoglobulins Consumption Share by End-Users in 2021

    • Figure South USA Intravenous Immunoglobulins Consumption Share by End-Users in 2027

    • Table Middle West USA Intravenous Immunoglobulins Consumption by Types from 2016 to 2027

    • Table Middle West USA Intravenous Immunoglobulins Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Intravenous Immunoglobulins Consumption Share by Types in 2016

    • Figure Middle West USA Intravenous Immunoglobulins Consumption Share by Types in 2021

    • Figure Middle West USA Intravenous Immunoglobulins Consumption Share by Types in 2027

    • Table Middle West USA Intravenous Immunoglobulins Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Intravenous Immunoglobulins Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Intravenous Immunoglobulins Consumption Share by End-Users in 2016

    • Figure Middle West USA Intravenous Immunoglobulins Consumption Share by End-Users in 2021

    • Figure Middle West USA Intravenous Immunoglobulins Consumption Share by End-Users in 2027

    • Table Northeast USA Intravenous Immunoglobulins Consumption by Types from 2016 to 2027

    • Table Northeast USA Intravenous Immunoglobulins Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Intravenous Immunoglobulins Consumption Share by Types in 2016

    • Figure Northeast USA Intravenous Immunoglobulins Consumption Share by Types in 2021

    • Figure Northeast USA Intravenous Immunoglobulins Consumption Share by Types in 2027

    • Table Northeast USA Intravenous Immunoglobulins Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Intravenous Immunoglobulins Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Intravenous Immunoglobulins Consumption Share by End-Users in 2016

    • Figure Northeast USA Intravenous Immunoglobulins Consumption Share by End-Users in 2021

    • Figure Northeast USA Intravenous Immunoglobulins Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Octapharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Octapharma

    • Figure Sales and Growth Rate Analysis of Octapharma

    • Figure Revenue and Market Share Analysis of Octapharma

    • Table Product and Service Introduction of Octapharma

    • Table Company Profile and Development Status of Grifols

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Grifols

    • Figure Sales and Growth Rate Analysis of Grifols

    • Figure Revenue and Market Share Analysis of Grifols

    • Table Product and Service Introduction of Grifols

    • Table Company Profile and Development Status of Sanquin

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanquin

    • Figure Sales and Growth Rate Analysis of Sanquin

    • Figure Revenue and Market Share Analysis of Sanquin

    • Table Product and Service Introduction of Sanquin

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of CSL Behring

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL Behring

    • Figure Sales and Growth Rate Analysis of CSL Behring

    • Figure Revenue and Market Share Analysis of CSL Behring

    • Table Product and Service Introduction of CSL Behring

    • Table Company Profile and Development Status of ADMA Biologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ADMA Biologics

    • Figure Sales and Growth Rate Analysis of ADMA Biologics

    • Figure Revenue and Market Share Analysis of ADMA Biologics

    • Table Product and Service Introduction of ADMA Biologics

    • Table Company Profile and Development Status of Kedrion Biopharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kedrion Biopharma

    • Figure Sales and Growth Rate Analysis of Kedrion Biopharma

    • Figure Revenue and Market Share Analysis of Kedrion Biopharma

    • Table Product and Service Introduction of Kedrion Biopharma

    • Table Company Profile and Development Status of Biotest

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biotest

    • Figure Sales and Growth Rate Analysis of Biotest

    • Figure Revenue and Market Share Analysis of Biotest

    • Table Product and Service Introduction of Biotest

    • Table Company Profile and Development Status of China Biologic Products

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China Biologic Products

    • Figure Sales and Growth Rate Analysis of China Biologic Products

    • Figure Revenue and Market Share Analysis of China Biologic Products

    • Table Product and Service Introduction of China Biologic Products

    • Table Company Profile and Development Status of Hualan Biological Engineering

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hualan Biological Engineering

    • Figure Sales and Growth Rate Analysis of Hualan Biological Engineering

    • Figure Revenue and Market Share Analysis of Hualan Biological Engineering

    • Table Product and Service Introduction of Hualan Biological Engineering

    • Table Company Profile and Development Status of Shire

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shire

    • Figure Sales and Growth Rate Analysis of Shire

    • Figure Revenue and Market Share Analysis of Shire

    • Table Product and Service Introduction of Shire

    • Table Company Profile and Development Status of Bharat Serum and Vaccines

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bharat Serum and Vaccines

    • Figure Sales and Growth Rate Analysis of Bharat Serum and Vaccines

    • Figure Revenue and Market Share Analysis of Bharat Serum and Vaccines

    • Table Product and Service Introduction of Bharat Serum and Vaccines

    • Table Company Profile and Development Status of LFB Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of LFB Group

    • Figure Sales and Growth Rate Analysis of LFB Group

    • Figure Revenue and Market Share Analysis of LFB Group

    • Table Product and Service Introduction of LFB Group


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.